6533b821fe1ef96bd127c0dd
RESEARCH PRODUCT
Prognostische Bedeutung des e-Cadherin beim papillären Schilddrüsencarcinom
Fernando BittingerE SternheimSiegfried WalgenbachJ. AndreasTheodor JungingerR. Gorgessubject
medicine.medical_specialtybusiness.industrymedicine.medical_treatmentThyroidectomyRetrospective cohort studymedicine.diseaseGastroenterologyThyroid carcinomaCardiothoracic surgeryInternal medicinemedicineCarcinomaImmunohistochemistrySurgerybusinessSurvival rateAbdominal surgerydescription
The prognostic significance of e-cadherin in papillary thyroid carcinoma was evaluated in a retrospective study. From September 1985 to December 1996, 113 patients underwent surgery for papillary thyroid carcinoma. Seventy-eight formalin-fixed, paraffin-embedded tissue samples were available for immunohistochemical analysis of e-cadherin expression. In 74 of these 78 patients the postoperative course is known for 2 months to 35.2 years (median 3.6 years, mean: 4.9 +/- 4.8 years). Reduced or negative e-cadherin expression ( 20%. Statistical analysis revealed e-cadherin expression ( 20%), synchronous distant metastasis (M0/pM1, cM1) and radicality of resection (R0/R1, 2) as significant risk factors for survival. Our findings provide evidence that e-cadherin is a prognostic factor in papillary thyroid carcinoma.
year | journal | country | edition | language |
---|---|---|---|---|
1998-02-01 | Der Chirurg |